REFERENCES
  1. Akinbami LJ, Moorman JE, Garbe PL, Sondik EJ. Status of childhood asthma in the United States, 1980–2007. Pediatrics 2009;123: S131–S145.
  2. Hasegawa K, Bittner JC, Nonas SA, Stoll SJ, Watase T, Gabriel S, Herrera V, Camargo CA Jr;. Multicenter airway research collaboration I. Children and adults with frequent hospitalizations for asthma exacerbation, 2012-2013: A Multicenter Observational Study. J Allergy Clin Immunol Pract. 2015; 3:751-8.
  3. Asher I, Pearce N. Global burden of asthma among children. Int J Tuberc Lung Dis. 2014; 18: 1269-1278.
  4. Global Initiative for Asthma. Global strategy for Asthma Management and Prevention, 2019. Available from:www.ginasthma.org (last accessed 31 July 2019).
  5. British guideline on the management of asthma. 2016. Available from:www.sign.ac.uk/assets/sign153.pdf(last accessed 31 July 2019).
  6. Alangari AA. Corticosteroids in the treatment of acute asthma. Ann Thorac Med. 2014; 9: 187-192.
  7. Chen AH, Zeng GQ, Chen RC, Zhan JY, Sun LH, Huang SK, Yang CZ, Zhong N. Effects of nebulized high-dose budesonide on moderate-to-severe acute exacerbation of asthma in children: a randomized, double-blind, placebo-controlled study. Respirology. 2013; Suppl 3:47-52.
  8. Edmonds ML, Milan SJ, Camargo Jr CA, Pollack CV, Rowe BH. Early use of inhaled corticosteroids in the emergency department treatment of acute asthma. Cochrane Database of Systematic Reviews 2012, Issue 12. Art. No.: CD002308. DOI: 10.1002/14651858.CD002308.pub2.
  9. Rodrigo GJ. Rapid effects of inhaled corticosteroids in acute asthma: an evidence-based evaluation. Chest 2006;130: 1301–1311.
  10. de Benedictis FM, Bush A. Corticosteroids in respiratory diseases in children. Am J Respir Crit Care Med. 2012; 185: 12-23.
  11. Kumar SD, Emery MJ, Atkins ND, Danta I, Wanner A. Airway mucosal blood flow in bronchial asthma. Am J Respir Crit Care Med. 1998; 158: 153-156.
  12. Beckhaus AA, Riutort MC, Castro-Rodriguez JA. Inhaled versus systemic corticosteroids for acute asthma in children. A systematic review. Pediatr Pulmonol. 2014; 49:326-34.
  13. Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 2015: 349, g7647–g7647.
  14. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Clinical safety data management: definitions and standards for expedited reporting [Accessed May, 2015]. Available at:http://www.pmda.go.jp/file/000156623.pdf
  15. Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 2011: 343, d5928.
  16. Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135.
  17. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557–560.
  18. Deeks JJ, Altman DG, Bradburn M. Statistical Methods for Examining Heterogeneity and Combining Results from Several Studies in Meta-Analysis. in Systematic Reviews in Health Care: Meta-Analysis in Context, Second Edition (ed. BMJ Publishing Group)
  19. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to metaanalysis. 2009, John Wiley & Sons.
  20. Sung L, Osmond MH, Klassen TP. Randomized, controlled trial of inhaled budesonide as an adjunct to oral prednisone in acute asthma. Acad Emerg Med. 1998; 5: 209–13.
  21. Sano F, Cortez GK, Solé D, Naspitz CK. Inhaled budesonide for the treatment of acute wheezing and dyspnea in children up to 24 months old receiving intravenous hydrocortisone. J Allergy Clin Immunol. 2000; 105: 699–703.
  22. Nuhoglu Y, Atas E, Nuhoglu C, Iscan M, Ozcay S. Acute effect of nebulized budesonide in asthmatic children. J Investig Allergol Clin Immunol. 2015; 15: 197–200.
  23. Upham BD, Mollen CJ, Scarfone RJ, Seiden J, Chew A, Zorc JJ. Nebulized Budesonide Added to Standard Pediatric Emergency Department Treatment of Acute Asthma: A Randomized, Double-blind Trial. Acad Emerg Med. 2011; 18: 665–673.
  24. Akhtaruzzaman M, Ahmed SU, Hoque MA, Choudhury AM, Hossain MA, Islam MN, et al. Effects of nebulized budesonide as an adjunct to standard treatment of asthma exacerbations: a randomized, double-blind, placebo-controlled trial. Mymensingh Med J. 2014; 23: 418–25.
  25. Alangari AA, Malhis N, Mubasher M, Al-Ghamedi N, Al-Tannir M, Riaz M, Umetsu DT, Al-Tamimi S. Budesonide nebulization added to systemic prednisolone in the treatment of acute asthma in children: A double-blind, randomized, controlled trial. Chest 2014; 145: 772–778.
  26. Razi CH, Akelma AZ, Harmanci K, Kocak M, Kuras CanY. The Addition of Inhaled Budesonide to Standard Therapy Shortens the Length of Stay in Hospital for Asthmatic Preschool Children: A Randomized, Double-Blind, Placebo-Controlled Trial. Int. Arch. Allergy Immunol. 2015;166: 297–303.
  27. Kassisse E, Prada L, Salazar I, García H, Kassisse J. Estudio aleatorizado abierto de niños con exacerbación aguda del asma tratados con esteroides inhalados. Rev Cubana Pediatr. 2017; 89: 165–176.
  28. Razi CH, Cörüt N, Andıran N. Budesonide reduces hospital admission rates in preschool children with acute wheezing. Pediatr. Pulmonol. 2017; 52: 720–728.
  29. Rodriguez-Martinez CE, Sossa-Briceño MP, Castro-Rodriguez JA. Advantage of inhaled corticosteroids as additional therapy to systemic corticosteroids for pediatric acute asthma exacerbation a cost-effectiveness analysis. J Asthma. 2019; Jun 17:1-10. doi: 10.1080/02770903.2019.1628254.
  30. Mendes ES, Cadet L, Arana J, Wanner A. Acute effect of an inhaled glucocorticosteroid on albuterol-induced bronchodilation in patients with moderately severe asthma. Chest. 2015;147:1037-1042.
  31. van den Brink KI, Boorsma M, Staal-van den Brekel AJ, Edsbäcker S, Wouters EF, Thorsson L. Evidence of the in vivo esterification of budesonide in human airways. Br J Clin Pharmacol. 2008; 66: 27-35.
  32. Horvath G, Wanner A. Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma. Eur Respir J. 2006; 27:172-87.
  33. Mendes ES, Pereira A, Danta I, Duncan RC, Wanner A. Comparative bronchial vasoconstrictive efficacy of inhaled glucocorticosteroids. Eur Respir J. 2003; 21: 989-93.
  34. Agertoft L, Andersen A, Weibull E, Pedersen S. Systemic availability and pharmacokinetics of nebulised budesonide in preschool children. Arch Dis Child.1999;80:241-7.